← FDA Drug Approvals (Drugs@FDA)

ACTONEL

NDA · New Drug Application · Sponsor: APIL · Approved 1998-03-27

Drug application

FDA Application #

NDA020835

Application type

New Drug Application

Brand name

ACTONEL

Generic name

RISEDRONATE SODIUM

Active ingredients

RISEDRONATE SODIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

APIL

Manufacturer

Allergan, Inc.

First approval

1998-03-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown